NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your Synopsys, Inc. (NASDAQ:SNPS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/synopsys-inc-lawsuit-submission-form?prid=176638&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

Recently, the Bright China 2025 Clear Vision China Myopia Prevention and Control Conference & International Myopia Symposium was held in Shanghai. During the conference, on October 26, Airdoc jointly organized a satellite session themed "Clinical Research and Prospects of PBM(R) Photobiomodulation" with several authoritative experts. At the session, clinical research data on the application of

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=176634&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of uniQure N.V. (NASDAQ: QURE) (“uniQure”). https://mma.prnewswire.com/media/2476890/Kessler_Topaz_Meltzer_and_Check__Logo.jpg On November 3, 2025, uniQure issued a press release revealing that the FDA notified the company that data for its AMT-130, an investigational

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Jefferies Financial Group Inc. ("Jefferies Financial Group Inc.") (NASDAQ:JEF) concerning possible violations of federal securities laws. On October 8, 2025, Jefferies announced that it and Point Bonita had approximately $715 million in

NEW YORK, NY / ACCESS Newswire / November 10, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=176636&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

(NASDAQ:JSPR), NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper Therapeutics, Inc. (NASDAQ: JSPR) between November 30, 2023 and July 3, 2025, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline. SO WHAT: If

JSPR DEADLINE ALERT: ROSEN, A TOP-RANKED LAW FIRM, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action – JSPR GlobeNewswire November 11, 2025 NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jasper

New York, Nov. 10, 2025 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only and does not constitute financial, investment, or gambling advice. Online wagering involves risk. Please gamble responsibly and only with funds you can afford to lose. If you register or make a purchase through links in this article, a commission

Betting Sites USA: BetUS Ranked Leading Sports Betting Site BetUS Dominates the 2025 Betting Sites USA Rankings With Unmatched Odds, Live Wagering, and Player Rewards. GlobeNewswire November 11, 2025 New York, Nov. 10, 2025 (GLOBE NEWSWIRE) — Disclaimer: This article is for informational purposes only and does not constitute financial, investment, or gambling advice. Online